IONS vs MLYS · rev $514.0M vs $2.17B cap
Ionis Pharmaceuticals Inc (IONS) versus Mineralys Therapeutics, Inc. Common Stock (MLYS) — a side-by-side from cached financials, not a winner call.
Ionis Pharmaceuticals Inc (IONS) is a biotechnology company listed on NASDAQ.
Mineralys Therapeutics, Inc. Common Stock (MLYS) is a biotechnology company listed on US.
Latest reported IONS revenue for 2026-06-30 was $514.0M. Net income was -$207.2M. IONS currently screens at market cap $12.28B.
MLYS does not have a complete income-statement cache yet.
IONS currently screens at market cap $12.28B. MLYS currently screens at market cap $2.17B.
Not investment advice. Open the IONS and MLYS stock pages for the full models.
Not investment advice.